{"allTrials": {"@totalCount": "1", "@xmlns": "http://www.67bricks.com/isrctn", "fullTrial": {"trial": {"@lastUpdated": "2008-06-30T00:00:00.000Z", "@version": "20", "isrctn": {"@dateAssigned": "2008-06-30T00:00:00.000Z", "#text": "95974322"}, "trialDescription": {"@thirdPartyFilesAcknowledgement": "false", "acknowledgment": "true", "title": "Brazilian pentavalent vaccine", "scientificTitle": "Immunogenicity and safety of Brazilian combined vaccine against diphtheria, tetanus, pertussis, haemophilus influenzae type B and hepatitis B (DTPw/HB/hib)", "acronym": null, "studyHypothesis": "The Brazilian combined diphtheria, tetanus, pertussis, haemophilus influenzae type B and hepatitis B (DTPw/HB/hib) vaccine is as immunogenic and safe as the current DTPw/Hib and HB vaccines administered separately.", "plainEnglishSummary": "Not provided at time of registration", "primaryOutcome": "Antibody titres to diphtheria, tetanus, pertussis, haemophilus influenzae (PRP) and hepatitis B, and seroprotection rate, measured after third dose, shoud be non-inferior to that from the reference vaccines (DTP/Hib and HB vaccines given separately).", "secondaryOutcome": "1. Adverse event after each dose shoud be equivalent to reference vaccines\n2. Consistency of production evaluated by equivalence in immunogenicity and safety of three lots of the experimental vaccine DTPw/HB/Hib", "trialWebsite": null, "ethicsApprovalRequired": "Old ethics approval format", "ethicsCommittees": null, "ethicsApproval": "Ethics approval received from the Fiocruz Ethics Committee on the 14th January 2007 (ref: 400/07)."}, "externalRefs": {"doi": "10.1186/ISRCTN95974322", "eudraCTNumber": null, "irasNumber": null, "clinicalTrialsGovNumber": null, "protocolSerialNumber": "ASCLIN/001/2007"}, "trialDesign": {"studyDesign": "Multicentre, non-inferiority randomised controlled trial, partially blinded.", "primaryStudyDesign": "Interventional", "secondaryStudyDesign": "Randomised controlled trial", "trialSettings": {"trialSetting": "Not specified"}, "trialTypes": {"trialType": "Treatment"}, "overallStatusOverride": null, "reasonAbandoned": null, "overallStartDate": "2008-03-17T00:00:00.000Z", "overallEndDate": "2009-09-30T00:00:00.000Z"}, "participants": {"recruitmentCountries": {"country": "Brazil"}, "trialCentres": {"trialCentre": {"@id": "705a0939-fcc5-4d99-aabe-974459d56b68", "name": "Rua Leoplodo Bulh\u00f5es 1480/820", "address": null, "city": "Rio de Janeiro", "state": null, "country": "Brazil", "zip": "21041-210"}}, "participantTypes": {"participantType": "Patient"}, "inclusion": "Healthy newborns (newborns and infants up to 7 months of age, of both sexes) whose parents/tutors understand the risk and benefits of the trial and agree to participate with written and informed consent.", "ageRange": "Child", "upperAgeLimit": {"@unit": "Months", "@value": "7.0"}, "gender": "Both", "targetEnrolment": "1200", "totalFinalEnrolment": null, "totalTarget": "1200 volunteers", "exclusion": "Newborns or mothers:\n1. Hepatitis B surface antigen (HBsAg) positive\n2. Human immunodeficiency virus (HIV) seropositive \n3. With positive serology for syphilis", "patientInfoSheet": "Not available in web format, please use the contact details below to request a patient information sheet", "recruitmentStart": "2008-03-17T00:00:00.000Z", "recruitmentEnd": "2009-09-30T00:00:00.000Z", "recruitmentStatusOverride": null}, "conditions": {"condition": {"description": "Diphtheria, tetanus, pertussis, hepatitis B and haemophilus influenzae type B diseases", "diseaseClass1": "Infections and Infestations", "diseaseClass2": "Bacterial infection of unspecified site"}}, "interventions": {"intervention": {"description": "1. Experimental group: vaccine (DTPw/HB/Hib) at 2, 4 and 6 months of age\n2. Control group: DTPw/Hib and HB vaccines in concomitant injections at different sites\n\nBoth groups will receive HB vaccine at birth.", "interventionType": "Drug", "pharmaceuticalStudyTypes": null, "phase": "Not Specified", "drugNames": "Combined diphtheria, tetanus, pertussis, haemophilus influenzae type B and hepatitis B (DTPw/HB/hib) vaccine, DTPw/Hib vaccine, HB vaccine"}}, "results": {"publicationPlan": "Not provided at time of registration", "ipdSharingStatement": null, "dataPolicies": {"dataPolicy": "Not provided at time of registration"}, "publicationDetails": null, "publicationStage": null, "biomedRelated": "false", "basicReport": null, "plainEnglishReport": null}, "outputs": null, "parties": {"funderId": ["Funder17918-0", "Funder17918-1"], "contactId": "Contact55901_17918", "sponsorId": "Sponsor54465"}, "miscellaneous": {"@xmlns:ssb": "http://www.67bricks.com/isrctn/functions", "ipdSharingPlan": "No"}, "attachedFiles": null}, "contact": {"@id": "Contact55901_17918", "title": "Dr", "forename": "Luiz Ant\u00f4nio Bastos", "surname": "Camacho", "orcid": null, "contactTypes": {"@xmlns:ssb": "http://www.67bricks.com/isrctn/functions", "contactType": "Scientific"}, "contactDetails": {"address": "Rua Leoplodo Bulh\u00f5es 1480/820 \nManguinhos", "city": "Rio de Janeiro", "country": "Brazil", "zip": "21041-210", "telephone": {"@xmlns:ssb": "http://www.67bricks.com/isrctn/functions", "#text": "+55 21 2598 2630"}, "email": {"@xmlns:ssb": "http://www.67bricks.com/isrctn/functions", "#text": "luiz.camacho@ensp.fiocruz.br"}}, "privacy": "Public"}, "sponsor": {"@id": "Sponsor54465", "organisation": "Bio-Manguinhos/Fiocruz (Brazil)", "website": "http://www.bio.fiocruz.br", "sponsorType": "Research organisation", "contactDetails": {"address": "c/o Akira Homma \nDirector\nAvenida Brasil 4365 \nManguinhos", "city": "Rio de Janeiro", "country": "Brazil", "zip": "21040-900", "telephone": {"@xmlns:ssb": "http://www.67bricks.com/isrctn/functions"}, "email": {"@xmlns:ssb": "http://www.67bricks.com/isrctn/functions"}}, "privacy": "Protected", "gridId": "grid.424703.6", "rorId": "https://ror.org/05gj5j117"}, "funder": [{"@id": "Funder17918-0", "name": "Brazilian Ministry of Health (Brazil)", "fundRef": null}, {"@id": "Funder17918-1", "name": "Brazilian Ministry of Science and Technology (Brazil)", "fundRef": null}]}}}